Richard H. Scheller

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Grace Wong-Sarad, by power of attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard H. Scheller

Form 4 holding Director

BridgeBio Pharma, Inc.

Security class
Common Stock
Shares / value
53,822
Estimated value
$2,043,621
Report date
16 Feb 2023
Price
$37.97
Ownership
Direct
Form 4 holding Director

BridgeBio Pharma, Inc.

Security class
Restricted Stock Units
Shares / value
12,783
Estimated value
$377,738
Report date
16 Feb 2023
Price
$29.55
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

23andMe Holding Co.

Security class
Class A Common Stock
Shares / value
895,961
Estimated value
$299,341
Report date
26 Aug 2024
Price
$0.3341
Ownership
Direct
Form 4 holding Director

Alector, Inc.

Security class
Stock Option (right to buy)
Shares / value
9,450
Estimated value
Report date
17 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

DICE Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
09 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Richard H. Scheller

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .